Foscavir and Invirase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Foscavir (foscarnet sodium) and Invirase (saquinavir mesylate). Common drug interactions include renal failure acute among females and aids encephalopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Foscavir and Invirase. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Foscavir?

Foscavir has active ingredients of foscarnet sodium. eHealthMe is studying from 1,631 Foscavir users. Check the latest studies of Foscavir.

What is Invirase?

Invirase has active ingredients of saquinavir mesylate. eHealthMe is studying from 2,690 Invirase users. Check the latest studies of Invirase.



On Jul, 04, 2026

21 people who take Foscavir and Invirase together, and have interactions are studied.

Foscavir and Invirase drug interactions.

What are the common drug interactions of Foscavir and Invirase, by gender? *:

female:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Blood uric acid increased
  3. Decreased immune responsiveness
  4. Genotype drug resistance test positive
  5. Anaemia (lack of blood)
  6. Cervix carcinoma stage 0 (abnormal cells are found in the innermost lining of the cervix. these abnormal cells may become cancer and spread into nearby normal tissue)
  7. Cervix carcinoma stage iii (cancer has spread to the lower third of the vagina, and/or to the pelvic wall)
  8. Hypokalaemia (low potassium)

male:

  1. Aids encephalopathy (malfunction of the brain as a result of hiv infection, variety of cognitive, motor, and behavioural abnormalities)
  2. Renal impairment (severely reduced kidney function)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Anaemia (lack of blood)
  5. Diarrhoea
  6. Lymphoma (cancer that begins in immune system cells)
  7. Pneumonia fungal
  8. Pyrexia (fever)
  9. Rash generalised (rash on most of body parts)
  10. Blood creatinine increased

What are the common drug interactions of Foscavir and Invirase, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Blood uric acid increased
  2. Cervix carcinoma stage 0 (abnormal cells are found in the innermost lining of the cervix. these abnormal cells may become cancer and spread into nearby normal tissue)
  3. Cervix carcinoma stage iii (cancer has spread to the lower third of the vagina, and/or to the pelvic wall)

30-39:

  1. Aids encephalopathy (malfunction of the brain as a result of hiv infection, variety of cognitive, motor, and behavioural abnormalities)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Blood amylase increased
  4. Blood creatinine increased
  5. Deafness
  6. Renal failure acute (rapid kidney dysfunction)

40-49:

  1. Decreased immune responsiveness
  2. Genotype drug resistance test positive
  3. Renal impairment (severely reduced kidney function)
  4. Anaemia (lack of blood)
  5. Blood creatinine increased
  6. Blood urea increased
  7. Difficulty in micturition (difficulty to urinate)
  8. Hypokalaemia (low potassium)
  9. Renal failure acute (rapid kidney dysfunction)

50-59:

  1. Blood alkaline phosphatase increased
  2. Blood amylase increased
  3. Lactic acidosis (low ph in body tissues)
  4. Muscle weakness (a lack of muscle strength)
  5. Muscular weakness (muscle weakness)
  6. Blood lactic acid decreased
  7. Pain
  8. Pain in extremity
  9. Blood uric acid increased
  10. Dysphagia (a condition in which swallowing is difficult or painful)

60+:

n/a

What are the existing conditions these people have? *

  1. Hiv Infection: 6 people, 28.57%
  2. Cytomegalovirus Chorioretinitis (infection of choroid and retina of the eye from virus): 3 people, 14.29%
  3. Pneumonia Fungal: 2 people, 9.52%
  4. Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 2 people, 9.52%
  5. Lymphoma (cancer that begins in immune system cells): 2 people, 9.52%
  6. Fever: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Foscavir and Invirase?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Foscavir and Invirase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Foscavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Invirase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Foscavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Invirase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on foscarnet sodium and saquinavir mesylate (the active ingredients of Foscavir and Invirase, respectively), and Foscavir and Invirase (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: